ReShape Lifesciences Files 8-K Report

Ticker: HIND · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1427570

Reshape Lifesciences Inc. 8-K Filing Summary
FieldDetail
CompanyReshape Lifesciences Inc. (HIND)
Form Type8-K
Filed DateJul 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: disclosure, exhibits, regulation-fd

TL;DR

ReShape Lifesciences filed an 8-K on July 15, 2025, covering disclosures and financial exhibits.

AI Summary

On July 15, 2025, ReShape Lifesciences Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Obalon Therapeutics Inc., is incorporated in Delaware and headquartered in San Clemente, California.

Why It Matters

This 8-K filing provides important updates and disclosures for ReShape Lifesciences Inc., which could impact investor understanding of the company's current status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report detailing disclosures and exhibits, without immediate news of significant financial events or strategic shifts.

Key Players & Entities

  • ReShape Lifesciences Inc. (company) — Registrant
  • July 15, 2025 (date) — Date of earliest event reported
  • Obalon Therapeutics Inc. (company) — Former company name
  • Delaware (jurisdiction) — State of incorporation
  • San Clemente, California (location) — Business address

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What was ReShape Lifesciences Inc. formerly known as?

ReShape Lifesciences Inc. was formerly known as Obalon Therapeutics Inc.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on July 15, 2025.

In which state is ReShape Lifesciences Inc. incorporated?

ReShape Lifesciences Inc. is incorporated in Delaware.

What is the business address of ReShape Lifesciences Inc.?

The business address of ReShape Lifesciences Inc. is 18 Technology Drive, Suite 110, Irvine, CA 92618.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding ReShape Lifesciences Inc. (HIND).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.